You searched for "infection"
Long-term treatment for diabetic macular oedema
2 April 2025
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
The authors set out to characterise anti-VEGF treatment patterns and long-term outcomes in patients with diabetic macular oedema. A retrospective analysis of over 190 thousand patients on the Intelligent Research in Sight registry was performed. Of these, 1236 eyes have...
Displacement of submacular haemorrhage – comparative study pneumatic displacement versus subretinal cocktail injection
3 October 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors report a multicentre retrospective interventional case series study comparing the outcome of submacular haemorrhage (SMH) using pneumatic displacement with intravitreal expansile gas versus treatment with pars plana vitrectomy (PPV) versus subretinal injection of tissue plasminogen activator (tPA), anti-vascular...
BT for Duane’s retraction syndrome esotropia
The aim of the study was to evaluate the correction of esotropia and face turn due to Duane’s retraction syndrome (DRS) type I. The mean age was 21 months (12-36 months). The mean dose of botulinum toxin (BT) was 5.6±1.8IU...Cavernous sinus syndrome
Anatomically the cavernous sinus is a plexus of multiple veins that are connected and within this plexus there are several important vascular and neurological structures. These include cranial nerves III, IV, V1 (and sometimes V2), VI as well as the...The results of the last survey Apr24
3 April 2024
| Amar Alwitry
|
EYE - General
It has been a few years now since we started these surveys and I continue to be amazed by the variance in our practice. As a patient, I think I would expect there to be more consistency and evidence-based practice....
The results of the last survey Feb25
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. The sample...My Top Five: Trinkets of fact or fiction
3 June 2024
| Nishant Aggarwal
|
EYE - General
Trinkets of adult wisdom are often delivered to children alongside warnings of catastrophic outcomes. In this article we present five ‘facts’ about eye health and vision and ask the question: to what extent are these ideas backed up by literature?...
My top five: Trinkets of fact or fiction
3 June 2024
| Nishant Aggarwal
|
EYE - General
Trinkets of adult wisdom are often delivered to children alongside warnings of catastrophic outcomes. In this article we present five ‘facts’ about eye health and vision and ask the question: to what extent are these ideas backed up by literature?...
The paediatric cataract: an overview of the embryology and pathophysiology
5 February 2020
| Samuel Augustus Fernando Aryee
|
EYE - Paediatrics, EYE - Strabismus, EYE - Cataract, EYE - Refractive, EYE - General
In the first of the two articles (see Part 2 here) on paediatric cataracts, Samuel Aryee reviews the aetiology of this condition. Cataracts arise from opacification of the natural transparent lens, which can cause partial or total blindness. Although the...
Do bilateral same day intravitreal injections increase the risk of endophthalmitis?
1 February 2019
| Tasmin Berman
|
EYE - Vitreo-Retinal
This large retrospective cohort study reviewed all patients who had bilateral intravitreal anti-vascular endothelial growth factor (VEGF) injections between April 2012 and August 2017. There were 101,932 procedures performed in 5890 patients. The two most common indications for injections were...
Treatment of infantile cataract with secondary IOLs
The authors examined whether secondary IOL insertion is helpful in the successful treatment of monocular infantile cataracts. Eleven children were reviewed: eight with cataract extraction at one to four months of age and three at five to seven months of...
Injection of methotrexate into silicone oil-filled eyes for grade C PVR
1 October 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Methotrexate (MTX) is an antineoplastic antimetabolite with immunosuppressant properties. Folate antagonism is known to contribute to the antiproliferative effects of MTX, and release of adenosine from cells and inhibition of polyamines may explain its anti-inflammatory effects. These activities contribute to...
